SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Withdrawal from Acquisition Process

17 Dec 2020 07:00

RNS Number : 9277I
Cranswick PLC
17 December 2020
 

THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (REGULATION (EU) NO. 596/2014).

For immediate release.

17 December 2020

Cranswick plc

Withdrawal from Acquisition Process

 

Further to its announcement of 16 December 2020, the Board of Cranswick plc today confirms that it has withdrawn from the acquisition process for Inspired Pet Nutrition Limited.

 

 

Enquiries

 

Powerscourt

Tel: 020 7250 1446

 

Nick Dibden / Lisa Kavanagh

 

 

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Steven Glover, Group Company Secretary.

This announcement and the information contained in it is restricted and is not for release, publication, distribution or forwarding, in whole or in part, directly or indirectly, in or into any jurisdiction in which such publication, release or distribution would be unlawful.

This announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, New Zealand, South Africa, Japan or any other jurisdiction in which the same would be unlawful. No public offering of any securities in connection with the equity fundraising referred to in this announcement is being, or will be, made in any such jurisdiction.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGPGCUPUPUPUQ
Date   Source Headline
24th Nov 20254:59 pmRNSDirector/PDMR Shareholding
3rd Nov 20255:44 pmRNSHolding(s) in Company
3rd Nov 202510:40 amRNSTotal Voting Rights
22nd Oct 20252:06 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSTotal Voting Rights
23rd Sep 20254:31 pmRNSDirector/PDMR Shareholding
17th Sep 20254:43 pmRNSHolding(s) in Company
15th Sep 20258:35 amRNSDirector/PDMR Shareholding
15th Sep 20258:33 amRNSDirector/PDMR Shareholding
11th Sep 202511:30 amRNSTotal Voting Rights
5th Sep 20254:03 pmRNSHolding(s) in Company
4th Sep 20257:56 amRNSHolding(s) in Company
2nd Sep 20255:00 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSHolding(s) in Company
26th Aug 20259:23 amRNSDirector/PDMR Shareholding
26th Aug 20257:07 amRNSHolding(s) in Company
4th Aug 20259:55 amRNSTotal Voting Rights
28th Jul 20252:51 pmRNSPoll Result for 2025 Annual General Meeting
28th Jul 20257:00 amRNSFirst quarter trading statement
24th Jul 20252:46 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSDirector/PDMR Shareholding
22nd Jul 20251:45 pmRNSHolding(s) in Company
9th Jul 20252:58 pmRNSDirector/PDMR Shareholding
8th Jul 20253:23 pmRNSTotal Voting Rights
8th Jul 20253:17 pmRNSDirector/PDMR Shareholding
30th Jun 202510:00 amRNSDirector/PDMR Shareholding
30th Jun 20259:57 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSAnnual Report and Accounts and Notice of AGM
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20253:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:48 pmRNSTotal Voting Rights
27th May 20257:00 amRNSHolding(s) in Company
22nd May 20256:25 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSPreliminary Results
13th May 20252:59 pmRNSHolding(s) in Company
6th May 20254:20 pmRNSHolding(s) in Company
25th Apr 202510:11 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSDirector/PDMR Shareholding
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20258:58 amRNSTotal Voting Rights
26th Mar 20254:08 pmRNSHolding(s) in Company
26th Mar 20252:22 pmRNSDirector/PDMR Shareholding
25th Mar 20254:12 pmRNSDirector/PDMR Shareholding
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.